Olsson Daniel S, Bryngelsson Ing-Liss, Ragnarsson Oskar
Department of EndocrinologyInstitute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden
Department of Occupational and Environmental MedicineÖrebro University Hospital, Örebro, Sweden.
Eur J Endocrinol. 2016 Jul;175(1):55-61. doi: 10.1530/EJE-16-0173. Epub 2016 May 4.
Increased mortality rates are found in women and young adults with non-functioning pituitary adenomas (NFPAs). This nationwide study aimed to investigate the burden of comorbidities in patients with NFPA and to examine whether gender influences the outcome.
NFPA patients were identified and followed-up from National Registries in Sweden. It was a nationwide, population-based study.
Standardised incidence ratios (SIRs) for comorbidities with 95% confidence intervals (CI). Comorbidities were analysed in all patients, both patients with and without hypopituitarism.
Included in the analysis were 2795 patients (1502 men, 1293 women), diagnosed with NFPA between 1987 and 2011. Hypopituitarism was reported in 1500 patients (54%). Mean patient-years at risk per patient was 7 (range 0-25). Both men (SIR 2.2, 95% CI: 1.8-2.5; P<0.001) and women (2.9, 2.4-3.6; P<0.001) had a higher incidence of type 2 diabetes mellitus (T2DM) than the general population, with women having a higher incidence compared with men (P=0.02). The incidence of myocardial infarction was increased in women (1.7, 1.3-2.1; P<0.001), but not in men. Both men (1.3, 1.1-1.6; P=0.006) and women (2.3; 1.9-2.8; P<0.001) had an increased incidence of cerebral infarction, with women having a higher incidence than men (P<0.001). The incidence of sepsis was increased for both genders. The incidence of fractures was increased in women (1.8, 1.5-1.8; P<0.001), but not for men.
This nationwide study shows excessive morbidity due to T2DM, cerebral infarction and sepsis in all NFPA patients. Women had higher incidence of T2DM, myocardial infarction, cerebral infarction and fracture in comparison to both the general population and to men.
在患有无功能垂体腺瘤(NFPA)的女性和年轻人中发现死亡率增加。这项全国性研究旨在调查NFPA患者的合并症负担,并研究性别是否会影响预后。
从瑞典国家登记处识别并随访NFPA患者。这是一项基于全国人口的研究。
计算合并症的标准化发病率(SIR)及95%置信区间(CI)。对所有患者,包括有和没有垂体功能减退的患者,进行合并症分析。
分析纳入了1987年至2011年间诊断为NFPA的2795例患者(1502例男性,1293例女性)。1500例患者(54%)报告有垂体功能减退。每位患者的平均风险人年数为7(范围0 - 25)。男性(SIR 2.2,95% CI:1.8 - 2.5;P<0.001)和女性(2.9,2.4 - 3.6;P<0.001)患2型糖尿病(T2DM)的发病率均高于普通人群,且女性发病率高于男性(P = 0.02)。女性心肌梗死发病率增加(1.7,1.3 - 2.1;P<0.001),而男性未增加。男性(1.3,1.1 - 1.6;P = 0.006)和女性(2.3;1.9 - 2.8;P<0.001)脑梗死发病率均增加,且女性发病率高于男性(P<0.001)。两性败血症发病率均增加。女性骨折发病率增加(1.8,1.5 - 1.8;P<0.001),男性未增加。
这项全国性研究表明,所有NFPA患者因T2DM、脑梗死和败血症导致发病率过高。与普通人群和男性相比,女性患T2DM、心肌梗死、脑梗死和骨折的发病率更高。